Truncus arteriosus, a double aortic arch, and a cervical aortic arch are all rare cardiovascular anomalies. We experienced a unique female newborn with the rare combination of truncus arteriosus with a cervical double aortic arch, which probably resulted from abnormal persistence of the bilateral 2nd or 3rd rather than the 4thembryonic aortic arches and failure of regression of the right 8th somitic segment of the right dorsal aorta. She presented with respiratory distress soon after birth, which was initially attributed to the vascular ring and hypertensive pulmonary arteries. Our inability to relieve her respiratory compromise by surgical division of the vascular ring and main pulmonary artery banding prompted the diagnosis of left main bronchial compression caused by a posteriorly displaced dilated ascending aorta that compressed the right pulmonary artery and left main bronchus against the descending aorta. The patient then underwent successful left main bronchus stent implantation. We speculate the cervical double aortic arch is redundant in nature and is a loose ring that may not cause tracheal compression. Nevertheless, a posteriorly displaced dilated ascending aorta in patients with truncus arteriosus may compress the right pulmonary artery and the main bronchus on the side of the aortic arch against the descending aorta.

1.
Bhan A, Gupta M, Kumar MJS, Kothari SS, Gulati GS: Persistent truncus arteriosus with double aortic arch. Pediatr Cardiol 2006;27:378–380.
2.
Snider AR, Enderlein MA, Teitel DJ, Juster RP: Two-dimensional echocardiographic determination of aortic and pulmonary artery sizes from infancy to adulthood in normal subjects. Am J Cardiol 1984;53:218–224.
3.
Kim YM, Yoo SJ, Kim WH, Kim TH, Joh JH, Kim SJ: Bronchial compression by posteriorly displaced ascending aorta in patients with congenital heart disease. Ann Thorac Surg 2002;73:881–886.
4.
Morrow WR, Huhta JC: Aortic arch and pulmonary artery anomalies; in Garson A Jr, Bricker JT, McNamara DG (eds): The Science and Practice of Pediatric Cardiology, ed 1. Pennsylvania, Lea & Febiger, 1990, vol II, pp 1423, 1428–1429.
5.
Bischoff HW, Leyva FR, Todd RH, et al: Truncus arteriosus communis persistens. A report of three cases. J Pediatr 1948;33:411–417.
6.
Rowe RD, Vlad P: Persistent truncus arteriosus. Report of 2 cases with right aortic arch. Am Heart J 1953;46:296–308.
7.
Victorica BE, Krovetz LJ, Elliot LP, Van Mierop LH, Bartley TD, Gessner IH, Schiebler GL: Persistent truncus arteriosus in infancy. A study of 14 cases. Am Heart J 1969;77:13–25.
8.
Calder L, Van Praagh R, Van Praagh S, Sears WP, Corwin R, Levy A, Keith JD, Paul MH: Truncus arteriosus communis. Clinical, angiographic and pathologic findings in 100 patients. Am Heart J 1976;92:23–38.
9.
Habbema L, Losekoot TG, Becker AE: Respiratory distress due to bronchial compression in persistent truncus arteriosus. Chest 1980;77:230–232.
10.
Capitanio MA, Wolfson BJ, Faerber EN, Williams JL, Balsara RK: Obstruction of the airway by the aorta: an observation in infants with congenital heart disease. AJR 1983;140:675–679.
11.
McElhinney DB, Reddy VM, Pian MS, Moore P, Hanley FL: Compression of the central airways by a dilated aorta in infants and children with congenital heart disease. Ann Thorac Surg 1999;67:1130–1136.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.